Scientists have reported that an experimental vaccine targeting one of the most common genetic drivers of pancreatic cancer, called mutant KRAS, is safe and generated a durable immune responses aimed at preventing the cancer.
Yogurt with probiotics are one of the latest health fads, but no one is sure they are doing anything at all and, if they are, that it is helping. Probiotics are defined by marketing groups as "live micro-organisms which, when administered in adequate amounts, confer a health benefit on the host, beyond the common nutritional effects." Proponents believe they facilitate fiber digestion, might boost the immune system and prevent or treat diarrhea. Dozens of bifidobacteria and lactobacilli are marketed in foods like yogurts and fermented milk products.
A decade ago there was mass hysteria among the fringes of science academia because American President George W. Bush limited federal funding for human embryonic stem cells to existing lines. Accompanying claims were that Alzheimer's Disease wouldn't be cured and Republicans hated science. In 2014, it is difficult to remember what all the fuss was about. California wants its $3 billion in hESC funding back, though that money did finally produce one paper, and adult stem cells have done all of the things hESC research was speculated to be able to do. Now, a final hurdle is about to be crossed: researchers have successfully 'reset' human pluripotent stem cells (iPSCs) to a fully pristine state, the point of their greatest developmental potential.
Around 3,000 farmers work 6,000 hectares in Veracruz, the west coast of Mexico, to grow potatoes (Solanum tuberosum). In recent decades, the fields of the Cofre de Perote area were affected by the presence of the golden nematode of potatoes (Globodera rostochiensis), also known as the yellow potato cyst nematode, a devastating plant pathogen, which reduced crop yields by more than 40 percent, leading to loss of income, loss of food and greater environmental strain due to making up the gap.According to records of the Institute of Ecology (INECOL) in Mexico, there were 6,000 cysts per kilogram of soil of the nematode - European Organization for the Protection of Plants guidelines say anything over 40 cysts will affect crop yield.
Rheumatoid arthritis causes chronic pain and inflammation in joints, such as those in the hands and feet, as well as knees and hips. Over time, rheumatoid arthritis can destroy the cartilage that lubricates and cushions the joints. In essence, it 'remodels' bones, leading to disfigurement, pain and reduced mobility.
Cartilage was previously thought to be a victim of an overzealous immune system but a new paper finds it has an active role in rheumatoid arthritis.
Dr Tommy Liu, Professor Ian Wicks, Dr Kate Lawler, Dr Ben Croker and colleagues from the Walter and Eliza Hall Institute made the discovery while investigating the role of the protein SOCS3 in controlling inflammation during rheumatoid arthritis.
Given its rampant crime, corruption and money issues, a lot of residents of Illinois publicly wish they could give Chicago away. They almost never had it at all.
The original proposed northern boundary of Illinois was a straight line from the southernmost tip of Lake Michigan to just south of the Rock and Mississippi River confluence - had it been approved, the northern 51 miles of the Illinois Territory would have become Wisconsin when it became a state in 1848.
Psoriasis is an autoimmune disease with symptoms which
include the formation of red inflamed lesions that appear on the skin, vary from mild to severe.
It affects around 125 million people worldwide. A new paper has found different types of dendritic cells in human skin have assorted functions in the early and more advanced stages of psoriasis. The scientists suggest that new strategies to regulate the composition of dendritic cells in psoriatic skin lesions might represent an approach for the future treatment of the disease.The scientists observed an increase in the accumulation of plasmacytoid dendritic cells in the psoriatic lesions of patients as well as in mice that are model organisms for the study of the disease.
There is a link between our brain structure and our tolerance of risk, find economists who say they have found the first stable 'biomarker' for financial risk-attitudes.
Does that mean there is a causal link between brain structure and behavior? Neuroscientists and psychologists tend to fall into that trap but the scholars in the Journal of Neuroscience avoid that trap.
Dr Agnieszka Tymula, an economist at the University of Sydney, and colleagues found that the gray matter volume of a region in the right posterior parietal cortex was significantly predictive of individual risk attitudes. Men and women with higher gray matter volume in this region exhibited less risk aversion.
"Nobody understands the cloud," shouts a character in a recent comedy about a couple trying to remove a private video from the Internet.
In reality, the cloud is completely understandable, and it's one of few areas in climate where the emissions costs are also. And because it is quantifiable it can benefit from combinatorial optimization. the famous rucksack problem where a traveler has to try and fit everything in without leaving anything behind.
Imagine being able to go from the hottest of hots to the coldest of colds, and endure both extreme droughts, where 97% of your body water is gone, and airless vacuums such as space.The African midge, Polypedilum vanderplanki, can do all that and an international team deciphered the genetic mechanism that makes it invulnerable to these harsh conditions.The midge is capable of anhydrobiosis, a unique state that allows an organism to survive after losing almost all of its body water, along with other severe conditions, such as extreme temperatures ranging from 90°C to -270°C, vacuums and high doses of radiation; all of which would be lethal to most other life forms.
Data from an initial representative 938-subject sample of a 4,800-subject colorectal cancer trial at Hvidovre Hospital, Copenhagen demonstrated that the NuQ® blood-based diagnostic platform is able to correctly diagnose 84% of colorectal cancers, including early-stage cancers.
Merck is discontinuing the clinical development program of its investigational MUC1 antigen-specific cancer immunotherapy tecemotide (L-BLP25) as a monotherapy in Stage III non-small cell lung cancer (NSCLC).Tecemotide is an investigational MUC1 antigen-specific cancer immunotherapy that is designed to stimulate the body's immune system to identify and target cells expressing the cell-surface glycoprotein MUC1. MUC1 is expressed in many cancers, including NSCLC, and has multiple roles in tumor growth and survival. Tecemotide was being investigated in the Phase III START2, START and INSPIRE trials for the treatment of unresectable, locally advanced Stage III NSCLC.
The U.S. Food and Drug Administration has approved Keytruda (pembrolizumab), a new immunotherapy drug to treat advanced melanoma after it was tested on more than 600 patients who had melanoma that had spread throughout their bodies. Because so many of the patients in the early testing showed significant long-lasting responses, the study was continued and the FDA granted the drug “breakthrough therapy” status, allowing it to be fast-tracked for approval. The largest Phase 1 study in the history of oncology, the research was conducted at UCLA and 11 other sites in the U.S., Europe and Australia.
